Marginal ulcer after mini gastric by-pass and sleeve gastrectomy with transit bipartition

Abstract

The aim of this study to present the incidence of marginal ulcer among patients who underwent laparoscopic mini gastric by-pass (MGBP) or laparoscopic sleeve gastrectomy with transit bipartition (SG-TB), and to determine demographic, clinical and surgical risk factors associated with marginal ulcer development. This case-control study was designed as a retrospective analysis of an SG-TB and MGBP surgical series. The marginal ulcer group consisted of 8 patients who developed marginal ulcers during their follow-up. The control group was formed with a randomly selected sample of 18 people matching according to age, sex and operation type among the remaining 626 patients. The median age of all patients included in the study was 51 (27-62) years. 75.0% of the marginal ulcer group and 66.7% of the control group were males (p = 1.000). Marginal ulcer developed in 1.26% of all patients who underwent bariatric-metabolic surgery, in 6.45% of patients who underwent MGBP, and in 0.99% of patients who underwent SG-TB. It was observed that the ulcers of all cases recovered completely. No perforation was observed in any patient, no surgical intervention was required, and no marginal ulcer-related mortality was observed. There was no significant difference between the marginal ulcer group and the control group in terms of surgical, clinical and demographic features. Considering our practices and results, it was thought that post-operative PPI treatment for at least 6 months had a preventive effect on marginal ulcer development, and PPI treatment used after marginal ulcer development had an important role in healing.